Low Testosterone and Fructose Combine to Worsen Fatty Liver in Mice

Why testosterone and diet were studied together

The interaction between hormones, diet and gut bacteria may help explain why some mice developed more liver fat when low testosterone coincided with high fructose intake. A study from Osaka Metropolitan University points to intestinal pyruvate as one possible link, though the findings have yet to be tested in people. The result suggests that these factors may matter in combination: looking at either hormone levels or diet alone could miss an effect that emerges when both are present.

That distinction matters because metabolic dysfunction-associated steatotic liver disease (MASLD) has several associated risk factors. Researchers led by graduate student Hiroki Takahashi and Associate Professor Naoki Harada examined how reduced testosterone and fructose affect the liver. MASLD affects about 40% of adult men worldwide, according to the study’s framing. Fat buildup in the liver is an early feature of the disease, and obesity, type 2 diabetes, low testosterone and high fructose intake have all been associated with it. Those associations don’t by themselves show that any one factor causes the disease, or explain how the factors might interact.

The team studied eight-week-old male mice in six groups. Some animals were castrated to lower testosterone, while others underwent a sham operation, giving researchers a comparison group that experienced an operation without the same hormone reduction. Within each set, mice received a control diet, fructose, or fructose alongside antibiotics. Researchers analyzed liver tissue and cells, blood plasma, cecal organic acids and gut bacteria. The design let them compare the effects of the exposures and examine whether changes in intestinal microbes or chemicals tracked with changes in the liver.

Two risk factors, a stronger combined effect

Low testosterone or fructose alone produced relatively modest changes in liver triglycerides. Together, however, they significantly increased liver fat and worsened fatty liver. That pattern is the study’s central finding: the combined effect was more pronounced than either exposure alone. It doesn’t show that the same interaction occurs in people, but it gives researchers a reason to investigate how hormone status might shape responses to diet.

Mice with reduced testosterone also developed heavier livers when given fructose; that increase was smaller in animals that received antibiotics. Antibiotics can alter gut bacteria, so this result is consistent with a role for the microbiome. It isn’t proof that bacteria alone caused the liver changes, since antibiotics can affect a complex community of microbes and the study’s other biological processes. Still, the difference gave the researchers a useful lead.

Here’s the thing: a dietary exposure can have different effects depending on the animal’s biological state. That’s a more useful question than treating fructose as a single, uniform risk. For readers following MASLD research, the study adds a possible interaction to investigate, rather than a reason to draw conclusions about individual diets or hormone levels.

Gut bacteria and pyruvate offer a possible explanation

The combined exposure was associated with shifts in gut bacterial composition, changes in liver gene activity and higher pyruvate levels in the cecum, a part of the large intestine. The antibiotic result and these changes led the researchers to investigate whether the gut microbiome helped drive the liver effects. The evidence points to a chain of possible links: altered microbes, more intestinal pyruvate, and greater fat accumulation when fructose is also present. Each link needs further study.

In experiments with primary liver cells taken from mice, pyruvate and fructose acted together to increase neutral lipid accumulation. Takahashi said the researchers found that altered gut microbiota raised intestinal pyruvate, while the cell experiments showed that pyruvate could amplify fructose’s effect on fat storage. The cell work offers a more direct test of how the two compounds might act on liver cells, but isolated cells don’t reproduce the many interactions occurring in a whole animal.

Pyruvate plays a role in energy metabolism, and its appearance here gives the researchers a candidate mechanism to examine. The study doesn’t establish that the same pathway drives fatty liver in humans. Nor does it show that pyruvate is the only signal connecting gut bacteria and the liver. A plausible mechanism, not a settled explanation.

That said, the combination of animal and cell experiments makes the finding more informative than a simple association between gut bacteria and liver fat. The experiments suggest a testable sequence, while leaving open whether it operates in people, how large its effect might be, and which parts of the sequence matter most.

What the findings could mean next

Harada said the next step is to clarify how pyruvate promotes triglyceride accumulation. The team hopes that work could inform research into drug development and dietary approaches to prevention. Those are research aims, not treatments supported by this study. Before the mechanism can guide either approach, researchers will need to establish whether it applies beyond these mouse experiments and identify what conditions alter the effect.

This is more significant than it looks as a research question: it asks whether a common dietary factor and a hormone change can combine through gut activity to affect liver fat. If you’re working in this space, the practical implication is that future studies may need to examine interacting factors rather than testing each one in isolation (and this is the part most people overlook). But the numbers here are underwhelming as a basis for human conclusions: the experiments involved mice and isolated mouse liver cells, and don’t tell us how a person’s risk changes.

The study was published in American Journal of Physiology-Endocrinology and Metabolism. Its relevance to human health remains to be established. Future work will need to test the proposed mechanism in people and determine whether intestinal pyruvate tracks with the liver changes seen in the mice.

Further work will test the mechanism

The next stage is mechanistic. Researchers need to determine how pyruvate might promote triglyceride accumulation and whether the gut changes observed in the mice are necessary for that effect. The antibiotic comparison offers a clue, but it doesn’t isolate which microbes or processes are responsible. A clearer account of those steps would help show whether the pathway is a useful target for further research.

The study leaves a careful but meaningful question for future work: could gut-derived pyruvate help explain why some biological conditions make the liver more responsive to dietary fructose? For now, the answer is limited to a possible explanation in mice. The human connection remains open.

Did Venus Eat Its Own Moon? Scientists Uncover a Shocking Possibility

237-Million-Year-Old Fossils Reveal an Amphibian That Shouldn’t Have Existed

The Brain Is More Capable of Healing Itself Than Scientists Thought

Scientists Discover Never-Before-Seen Molecules With Cancer-Fighting Potential

Stay informed with ScienceDaily's free email newsletter, updated daily and weekly. Or view our many newsfeeds in your RSS reader:

Keep up to date with the latest news from ScienceDaily via social networks:

Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?